Laura Shawver

Director

Laura Shawver (Director) filed 5 Form 4 reports in the past 24 months (0 purchases, 5 sales), most often in SPRY. The largest single filing was $2.7M of SPRY (199,099 sh across 3 lots, as filed), executed Dec 2 2024.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 5 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$5.0M

shares × price, as filed

Last traded

Apr 7 2025

Filed Apr 8 2025

Open performance→

Volume by month

Buys $0 Sells $5.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Not on file 5 filings

Sector per market data · by filing · past 24 months

Most traded names

SPRY SPRY SPRY · 0 buys · 5 sells 5 filings

Recent filings

SPRYSALE ARS Pharmaceuticals, Inc. View filing → $615K
50,002 sh × $12.30
Exec Apr 7 2025
Filed Apr 8 2025 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. View filing → $556K
49,600 sh × $11.21
Exec Mar 6 2025
Filed Mar 7 2025 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. View filing → $616K
50,000 sh × $12.31
Exec Feb 3 2025
Filed Feb 4 2025 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. View filing → $555K
50,000 sh × $11.10
Exec Jan 6 2025
Filed Jan 7 2025 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. View filing → $2.7M
199,099 sh across 3 lots
Exec Dec 2 2024
Filed Dec 4 2024 · 5:30 PM ET